Flerie Commits to Pro Rata Share of Xspray Pharma's SEK 90 Million Rights Issue

Bitget2026/11/06 08:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Flerie will subscribe for its pro rata share of Xspray Pharma’s approximately SEK 90 million rights issue.
Its existing stake in Xspray Pharma is 17%.
Xspray Pharma has secured approximately SEK 104 million in subscription commitments for the rights issue and an overallotment issue.
Proceeds will support Dasynoc and Nilopki launch preparations, advance the development pipeline and strengthen future manufacturing capacity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Flerie AB published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Flerie Commits to Pro Rata Share of Xspray Pharma's SEK 90 Million Rights Issue

You may also like

Crypto prices